GNG12-AS1

gene
On this page

Summary

GNG12-AS1 (GNG12, DIRAS3 and WLS antisense RNA 1, HGNC:43938) is a long non-coding RNA gene on chromosome 1p31.3.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:43938
Approved symbolGNG12-AS1
NameGNG12, DIRAS3 and WLS antisense RNA 1
Location1p31.3
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000232284
Ensembl biotypelncRNA
OMIM615406
Entrez100289178
RNAcentralURS0000759D5C — lncRNA, 2247 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 11 lncRNA

ENST00000413628, ENST00000414904, ENST00000420587, ENST00000434072, ENST00000688125, ENST00000786419, ENST00000786420, ENST00000786421, ENST00000826363, ENST00000826364, ENST00000826365

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000413628 — 9 exons

ExonStartEnd
ENSE000015937686812112568121241
ENSE000015979766810265568102727
ENSE000016116206809972968099792
ENSE000016375856811745168117732
ENSE000016921996820196968202987
ENSE000016944076783230967832436
ENSE000017411216807180068071873
ENSE000017449776795615667956262
ENSE000017965946809864368098836

Expression profiles

Bgee: expression breadth ubiquitous, 127 present calls, max score 82.88.

FANTOM5 (CAGE): breadth broad, TPM avg 0.9706 / max 85.8475, expressed in 560 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
34300.7444396
34290.226281

Top tissues by expression

127 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.88gold quality
esophagogastric junction muscularis propriaUBERON:003584175.17gold quality
gall bladderUBERON:000211074.87gold quality
calcaneal tendonUBERON:000370174.23gold quality
lower esophagus muscularis layerUBERON:003583374.18gold quality
lower esophagusUBERON:001347374.15gold quality
corpus callosumUBERON:000233673.53gold quality
mucosa of stomachUBERON:000119973.49gold quality
body of pancreasUBERON:000115073.31gold quality
skin of abdomenUBERON:000141673.30gold quality
endometriumUBERON:000129572.86gold quality
zone of skinUBERON:000001472.48gold quality
left ovaryUBERON:000211972.24gold quality
skin of legUBERON:000151171.77gold quality
ovaryUBERON:000099271.76gold quality
smooth muscle tissueUBERON:000113571.58gold quality
stromal cell of endometriumCL:000225571.54gold quality
muscle layer of sigmoid colonUBERON:003580571.26gold quality
rectumUBERON:000105271.08gold quality
right ovaryUBERON:000211870.97gold quality
esophagusUBERON:000104370.87gold quality
pancreasUBERON:000126470.83gold quality
endocervixUBERON:000045870.75gold quality
uterine cervixUBERON:000000270.50gold quality
fundus of stomachUBERON:000116070.37gold quality
stomachUBERON:000094570.09gold quality
tibial nerveUBERON:000132369.92gold quality
ectocervixUBERON:001224969.71gold quality
right uterine tubeUBERON:000130269.70gold quality
adrenal tissueUBERON:001830369.70gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.30

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • This study showed that while most siRNAs silence GNG12-AS1 post-transcriptionally, siRNA complementary to exon 1 of GNG12-AS1 suppresses its transcription by recruiting Argonaute 2 and inhibiting RNA polymerase II binding. (PMID:26832224)
  • Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3beta/beta-catenin pathway. (PMID:32735016)
  • Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters. (PMID:38277283)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Zaki syndrome